ArticleThe journal of allergy and clinical immunology. In practicePublished
Mepolizumab reduces oral corticosteroid use across distinct severe asthma phenotypes: 2-year REALITI-A study
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- The journal of allergy and clinical immunology. In practice
- Published
- Topic
- Clinical care
- Subject terms
- IgE; Severe asthma; Mepolizumab; Real World; Oral Corticosteroid; Atopic Status; Baseline Blood Eosinophil Count; Baseline Feno; Omalizumab Eligibility; Realiti-a
- PubMed ID
- 42918296
- Open access
- Yes, open
- Added to directory
- Source checked